New research demonstrates the promise of cancer immunotherapy against gray zone lymphoma, potentially paving the way for clinical trials utilizing this strategy in this and related conditions.
New research demonstrates the promise of cancer immunotherapy against gray zone lymphoma, potentially paving the way for clinical trials utilizing this strategy in this and related conditions.